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SA HeArt® CongreSS 2019 - MeSSAge FroM tHe PreSIDent
Firstly it has been an honour to serve in the capacity as SA Heart® President.
In November last year, the SA Heart® Board met for a 2-day strategy session to discuss our structure, vision and mission, as 
well as a new way forward for our association. This meeting was ably facilitated by Mr Chandu Kashiram, who is a self-
employed business consultant – with particular expertise in risk management, compliance, ethics, governance, as well as 
internal control and financial management. We are extremely fortunate and grateful that Chandu has volunteered these 
services to SA Heart®. 
SA Heart®’s vision is to advance Cardiovascular Care for all South Africans, and as the scientific leaders in this country, we have 
identified 4 main pillars that underpin our goals: science, education, membership and policy. If we align all our efforts to these 
key values, we will achieve our mission, which is to champion equitable, sustainable healthcare, leading and innovating 
in the cardiovascular sciences, educating professionals, our members and the community, and, importantly, to attempt to 
influence healthcare policy. Our direction must involve the entire SA Heart® family, if we are to remain the key opinion leaders 
and the go-to organisation in cardiovascular health. We sincerely hope that you will follow us enthusiastically on this path. 
We are now in the process of aligning our Memorandum of Incorporation into a new model. Our vision, mission and strategic 
pillars, combined with a code of conduct the Board has developed, will firstly influence the direction of the Board, the work in 
our standing committees, our regional branches, and special interest groups (SIGs). 
Our 4 standing committees have often indicated that their mandate is unclear. We therefore have drawn new terms of 
reference for them to function more clearly. It is also imperative that all SIGs have representation within these committees.
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It has been decided to amalgamate the Education and 
Fulltime Salaried committees, as they are greatly involved 
in similar aspects of work. This new committee will be 
responsible for educational programmes for our members 
(together with SIG programmes and regional CPD 
accredited meetings). 
The Ethics and Guidelines Committee will peruse new 
editions of ESC guidelines; consider whether they would 
need a local position statement/comment; and respond 
with commentaries on the ethics of current important 
cardiovascular-related issues in the news. The committee’s 
mandate states that personal ethics of practitioners are not 
the gambit of this committee. I, however, believe that we 
should play such a role. A recent complaint (from a patient 
with regard to a particular cardiology practice) was however 
successfully resolved by Dr Osrin, before this could have 
been escalated to the Health Professions Council. We 
therefore believe that such intervention may well avoid 
further difficult and legal consequences. 
SA Heart® was also recently approached by Discovery 
Health regarding a cardiac technology practice who 
requested accreditation and reimbursement for a rarely 
required and used therapy, external counterpulsation 
(ECP), in patients with angina. A consensus statement (by 
the Ethics and Guidelines Committee) was developed after 
considering all published evidence, guidelines and a range of 
expert opinions thereof. Our final position is that ECP 
cannot be an alternative to accepted conventional medical 
therapy, PCI/CABG in such patients. A cardiologist/cardiac 
surgeon should decide on ECP only in those with intractable 
angina, after exhausting maximal medical treatment and all 
possibilities for revascularisation. The practice has requested 
formal engagement with SA Heart® and we have declined 
such interaction. 
The SASCI Private Practice Committee (PPC) will continue 
to represent SA Heart® as our PPC. There is no point in 
duplicating such a committee under SA Heart® as well. The 
Board has thanked and expressed our gratitude to SASCI. 
Dr JP Theron has resigned as the chairman of the PPC. We 
are very grateful to JP for his work in the past. Dr J Vorster 
has now been appointed chairman. The PPC will also now 
have wider representation from all of the SIGs. The main 
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objective for this year is a CPT (Current Procedural 
Terminology)  cross-walk to determine what the billing/
coding will look like under CPT as opposed to the usual 
SAMA coding. Once the cross-walk has been completed, 
we will engage with the funders for a cost analysis thereof. 
Karen van der Westhuizen (independent clinical coding 
consultant and auditor) has been consulted and we have 
had a number of meetings as such. The cross-walk is 
presently in process and will be finalised in the next few 
months. CPT takes the ambiguity out of the whole coding 
process and disincentivises practitioners from over servicing; 
it rather rewards for appropriate management. The ultimate 
aim in the next 2  -3 years will be to develop a full-time 
business unit with permanent staff/experts to take care of 
our private practice member’s issues, and to engage with 
funders when problems arise. It is important that SASCI is 
presently funding the PPC activities. In the future, a full-time 
business unit will have to be funded by a monthly fee to all 
those who require the PPC service. 
Recent PPC issues – SAMA mistakenly placed a rule that 
code 1252 (coronary angiography) cannot be charged 
when an angioplasty is performed! This was picked up by 
2 of the funders and potentially would result in huge 
consequences for those in private practice. Fortunately, 
SAMA has agreed to immediately correct this mistake. They 
have assured the PPC that they will in future constructively 
engage with us. Dr Vorster met with SAMA last week in this 
regard. We recently have resolved several other issues with 
various funders. I ask those who request PPC assistance to 
be patient with the committee; they are not full-time 
employees in terms of performing these duties. We are also 
presently engaging with funders regarding audits of our 
members, which we wish to speedily resolve. 
The SA Heart® 2019 Congress is fast approaching 
(21 October - 3 November). “Meeting the Needs for 
Africa” will be held in conjunction with PASCAR, Africa 
PCR, the Cardiovascular Magnetic Resonance Congress of 
South Africa (SA-CMR) and the African Heart Network 
(AHN). The coming together of 5 major groups will be an 
important milestone for cardiology in Africa. Our theme 
“Meeting the Needs for Africa” is highly relevant in an ever 
changing landscape and epidemic of cardiovascular disease 
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(CVD). It is now timeous and most appropriate to hold 
SA Heart® 2019 in association with AfricaPCR, a practical 
case-based interventional cardiology programme. PCR 
encompasses interventional cardiology in Africa and blends 
extremely well with the overall theme. SA-CMR will bring a 
unique imaging dimension. Advocacy and policy will be the 
focus of AHN to identify and address our unmet needs, if 
we are to reduce the burden of CVD – a stated aim of 
the WHO. SA Heart® 2019, PASCAR, AfricaPCR, SA-CMR 
and AHN will stimulate a creative exchange of ideas and 
will offer many opportunities to network with both local 
and international colleagues. I wish to thank Dr Rob Dyer 
and the KwaZulu-Natal Scientific Committee for all their 
hard work in developing the programme. An outstanding 
platform of leaders and teachers will provide 4 days of 
scintillating cardiovascular science and medicine. I sincerely 
look forward to welcoming you all next month to the 
Sandton Convention Centre. 
We are planning to form a new congress committee to 
streamline organisation and the scientific programme 
planning. We want to avoid “re-inventing the wheel” every 
year, with a committee that has never before organised 
a national congress. The historic rotation through the 
branches will be incorporated by asking the respective 
branches to appoint 2 representatives to serve in a parti-
cular year. As has always been customary, the congress 
committee will have representation from all interested 
SIGs. While experienced convenors will form the initial 
core of the committee, younger members will also be 
recruited. We need emerging, energetic and youthful 
leaders on board with us. 
The theme for SA Heart® 2020 will be “2020: Back to the 
Basics”. We want to get back to the fundamental basis of 
cardiovascular disease and cardiac practice. We are 
presently in the planning phases and we will continue to 
update you in this regard. We welcome our long-term 
partnership with AfricaPCR.
We continue to strengthen our relationship and membership 
of the European Society of Cardiology (ESC), whose 
mission is to reduce the burden of CVD. The latter aligns 
with our stated aims. 
We also held a SA Heart®-ESC joint symposium, “Infection, 
inflammation and the heart” at the recent ESC 2019 
congress in Paris. The session was really well attended and 
encompassed – Dr F Thienemann, HIV and cardiovascular 
disease in the era of antiretrovirals; Prof M Ntsekhe, What 
is new in the management of tuberculous pericarditis; and 
Dr K Klinge, Myocarditis: update on therapy. 
At ESC 2019, I was honoured to represent SA Heart® at 
the Affiliated Cardiac Societies Presidents meeting, in 
addition to a meeting with the ESC leadership, together 
with Dr B Cupido and Mrs E Dau. ESC requests us to give 
our local perspectives for publication with the various 
future planned ESC Practice Guidelines. The ESC would like 
to better cater for such recommendations – especially for 
regions such as Africa. 
We are proud that Prof K Sliwa is the current President of 
the World Heart Federation (WHF). SA Heart® had a 
strong presence at the WHF congress (Dubai in December 
2018). Our speakers and booth/association presence 
promoted our combined SA Heart® 2019, PASCAR, 
AfricaPCR, SA-CMR and AHN congress. Through our 
membership of WHF, we received 2 free registrations for 
the ESC-WHF congress, which were passed on to our 
members. 
Continued on page 262
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SA Heart® recently partnered with the ESC for angina 
awareness month. The project was funded by Servier 
Laboratories. We thank all of those who were involved in 
media interviews to educate and inform the public about 
the significance of angina. We have been informed that the 
campaign had achieved a significant reach and perhaps has 
even saved some lives. 
Please follow SA Heart® on social media (Facebook and 
Twitter) with our extremely vibrant programme. In this 
regard I thank Professor Zühlke and Carrine Visagie. 
Facebook remains our strongest social media platform and 
posts have reached 89 250 individuals – up from 20 000 
since the beginning of this year. The following is interestingly 
predominantly female (72%), with the greatest percentage 
aged 25 - 34 years. The community is very responsive in 
terms of sharing posts, as well as commenting and 
responding to them. We currently have more followers on 
Facebook than the Heart & Stroke Foundation of South 
Africa. Twitter growth remains a challenge (it’s harder to 
advertise effectively on this platform). Please help us to 
grow our Twitter community by sharing our posts. Please 
would you also forward any local and relevant content for 
inclusion on these platforms.
MeSSAge FroM tHe PreSIDent continued
Our SA Heart® Journal is now CPD accredited and a CPD 
questionnaire is free to take for members on the MPC 
platform. Please use this.
This year is the 20th anniversary of SA Heart®. In celebration, 
we will be launching an intensive media campaign to 
highlight our work, the achievements of our members, and 
also our plans for the future. We look forward to sharing 
these and other events with you in the coming months. 
Please do not hesitate to contact me with any 
suggestions. I also invite you to co-opt 
yourselves onto the various committees. We 
need more committed members to assist and 
to contribute. 
I look forward to further engagement and robust 














World Heart  www.world-heart-federation.org
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Please also consult the SA Heart® online calendar at www.saheart.org/events/eventcalendar for constant updates 
as well as a number of ISCAP workshops and SASCI/SA Visiting Professor evening lectures around the country.
PoPULAr CongreSSeS For 2019/2020
 CongreSS DAte CItY CoUntrY
AHA 2019 ScIeNtIfIc SeSSIONS 16 - 18 November 2019 Philadelphia  United States
   of America
https://professional.heart.org/professional/index.jsp
PcR LONdON VALVeS 17 - 19 November 2019 London  United Kingdom
https://www.escardio.org/Congresses-&-Events/PCR-London-Valves 
cSI AfRIcA 2019 29 - 30 November 2019 Dar es Salaam  Tanzania
www.csi-congress.org/csi-africa.php
eUROecHO 2019 04 - 07 December 2019 Vienna  Austria
https://www.escardio.org/Congresses-&-Events/EuroEcho 
ScAI 2019 fALL feLLOwS cOURSeS 07 - 10 December 2019 Las Vegas  United States
   of America
https://www.scai.org
SOUtH AfRIcAN SOcIety Of ANAeStHeSIA 11 - 15 March 2020 Pretoria  South Africa
cONgReSS
https://www.sasacongress.com
Acc 2020 tOgetHeR wItH 28 - 30 March 2020 Chicago  United States
wORLd cONgReSS Of cARdIOLOgy   of America
https://accscientificsession.acc.org
https://www.world-heart-federation.org/congress/about
eUROgUcH 2020 17 - 18 April 2020 Leeuven  Belgium
https://www.escardio.org/Congresses-&-Events/Working-group-events/EuroGUCH
SA HeArt® AnD AFrICA PCr 2020 21 - 25 october 2020 Sandton  South Africa
CongreSS 
http://www.saheart.org/2020
CeLeBrAtIng 20 YeArS oF SA HeArt® At tHe 2019 CongreSS
Please visit the SA Heart® Booth in the exhibition centre!
tell us about your contribution to advancing heart health  
for all living in South Africa!
collect information on SA Heart®.








SA HeArt® eDUCAtIon AnD FULLtIMe SALArIeD CoMMIttee
education committee members
Ashley Chin, Jens Hitzeroth, Ebrahim Hoosen, Hopewell Ntsinjana, Shaheen Pandie, Alfonso Pecoraro, Timothy Pennel and 
Nqoba Tsabedze.
Fulltime Salaried committee members
Antoinette Cilliers, Anupa Patel, Jacques Scherman, Timothy Pennel, Risenga Chauke, Nqoba Tsabedze, Makoali Makotoko and 
Adele Greyling
The role of the education committee continues to evolve. Where the committee previously directed most educational activities, 
it now plays more of an oversight role, ensuring equitable support for all interest groups that fall under the banner of SA Heart®. 
Many successful education activities have been organised over the past year and have been well attended by society members. 
ISCAP in particular, continues to grow from strength to strength. The biggest challenge, however has been the changing interaction 
with our industry partners. As you will all be aware, the new MedTech rules came into effect in January 2018 and have changed 
the landscape of financial support for educational activities in a very drastic way. The pilot project for implementation of these 
rules was the annual Africa PCR Congress held in March 2018 in Cape Town. Attendance of this Congress fell significantly, 
particularly in terms of allied healthcare professionals, who did not manage to secure support to attend the meeting under the 
new rules. Similarly, with Euro PCR and ESC, the number of South African delegates attending these meetings has fallen sharply. 
This has occurred despite many reassurances from our industry partners that the degree of support for these independently 
sponsored congresses would not be significantly affected. Clearly, more has to be done between SA Heart® and our industry 
partners to ensure that the new rules do not result in the death of further education and training in cardiology, particularly for 
the South African medical community. This will continue to be a challenge not only for the education committee, but for the 
SA Heart® executive as a whole together with the executives of all the special interest groups.
The SA Heart® Journal is now CPD accredited. Each Journal, except for the Congress issue which holds the congress 
abstracts, has 2 CMEs which are free to take for SA Heart® members on the Medical Practice Consulting website 
https://www.mpconsulting.co.za/journals.
Lastly, may I once again take the opportunity to encourage all society members to actively participate in our educational 
activities. Without member participation, our collective knowledge begins to stagnate which impacts on the quality of care 
we provide our patients.
tawanda Butau and Blanche Cupido
Chairpersons of the education and Fulltime Salaried committee
AnnUAL rePortS 2019
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etHICS AnD gUIDeLIneS CoMMIttee
the Committee has reviewed a few matters over the past year: 
 ■  Prepared and submitted a report on Counterpulsation;
 ■  Terms of Reference of the SA Heart® E&G Committee were submitted for discussion; and
 ■  Complaint received from a patient concerning the treating cardiologist was resolved by discussion and to the satisfaction of 
all parties.
Les orsin, Chairman, ethics and guidelines Committe
SA HeArt® regIStrY – SHAre
Committee members
Mpiko Ntsekhe (Chairperson), Erika Dau, Elizabeth Schaafsma, Karen Sliwa, Francis Smit, Jacques Scherman, Hellmuth Weich, 
Ashley Chin and Martin Mpe. 
SHARE has now run as a SA Heart® prospective registry programme for 3 years, and the model for independent funding and 
functioning can be considered successful. The primary aims for the year 2018 - 2019 included consolidation of the progress from 
the previous year and recruitment of 2 new registries, as well as improving patient care through providing local data showing 
outcomes, and transparent presentation of data from the registries.
The SHARE-TAVI registry is now running very well. All TAVI sites in the country are active with the overall case capture rate 
exceeding 92%, which is a great achievement for a voluntary participation registry. Over 850 TAVIs have been captured to date, 
and over 1 180 patients have been evaluated for TAVI and entered into the registry. More than 150 patients still await funding 
decisions regarding their TAVI procedures. However, looking at the data for 2019 only, the average number of days for a funding 
decision to be made has dropped to 72 days, from +180 days when the registry was first initiated – so the high number of patients 
awaiting decisions reflects that a greater number of patients are being referred for TAVI evaluations, rather than that decisions 
remain outstanding for a lengthy period.
In line with SHARE’s commitment to disseminate the data and information generated from the projects through publication and 
presentation of abstracts and papers, abstracts have been accepted and presented at EuroPCR 2019, ESC 2019 and locally at this 
year’s SA Heart®/PCR combined Congress. TAVI participants have been invited to feedback meetings at the SA Heart® Congress, 
as a forum to gather participants together conveniently for dissemination of information. With 45% of TAVI patients having 
completed their 1-year follow up, we are now in a position to offer more substantive data for publication, and are busy with the 
first manuscript on the SA TAVI data.
Prof Karen Sliwa of the Hatter Institute at UCT, and Dr Priya Soma-Pillay lead the SHARE Cardiac Disease and Maternity Registry 
(CDM), which has come to the end of its life cycle. Data entry has been closed on this project and as Prof Sliwa’s responsibilities 
at WHF have increased, she has handed over the lead in reporting on this registry to Dr Ferial Azibani, who is now in the process 
of preparing the first manuscript on this patient cohort.
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The new Atrial Flutter/Fibrillation registry, SHARE-SAFFR, led by Dr Martin Mpe and Prof Ashley Chin, has been developed and 
tested by the Investigators, and ethics approval has been obtained for the initial sites. A further 12 sites have been identified and 
are in the process of obtaining ethics approval. Data capture will begin synchronously at all sites once the ethics approval for the 
remaining sites has been obtained. There will be an Investigator meeting at the SA Heart® Congress for all site personnel to attend 
– to be briefed on developments and to discuss registry-related queries.
In addition to the initiation of SHARE-SAFFR, 3 additional device and drug registries are in contention to come on board 
pending ongoing evaluation and registration process at SAHPRA. The draft dataset for the ICD registry led by Drs Klug and Moses, 
has been developed, and will shortly be circulated to the HEFFSA and CASSA members for comment.
Fundraising remains a priority for the continued development and running of all the registry programmes. We are tremendously 
grateful to Medtronic, Edwards Life Sciences and Pfizer for the very generous support of the SHARE registry programmes. 
This continued support enables the maintenance of the registries over the next 2 years, and allows for extended follow-up data 
to be collected, as well as supporting the continued analysis and publication of the outcomes – which has been one of the 
cornerstone aims of the SHARE registries.
We look forward to continued growth in 2019 - 2020 as we generate the type of local data and information that will influence 
and improve clinical practice, patient care, and public policy in the future. The committee remains thankful to individual members 
of SA Heart®, the SA Heart® Exco, industry partners, funders and hospital groups for their continued interest and support of 
SHARE, and of course most importantly to the participants at all our sites.
elizabeth Schaafsma and Prof Mpiko ntsekhe, Chairperson, SHAre Committee
AnnUAL rePortS 2019 continued
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SASCI/SteMI SA
International arena
SteNt-SAVe A LIfe! Initiative
This year marks the 10th anniversary of the Stent-Save a Life! global initiative, whose aim is to reduce morbidity and mortality from 
acute coronary syndrome on a global level. Japan, Taiwan and Uruguay have now joined the initiative and the number of participating 
countries has risen to a total of 32.
The project’s objective is to develop a STEMI network guide (Blueprint) aimed at helping countries set up their own efficient 
networks. This is based on the Hub and Spoke model that has successfully implemented in India. Representatives for 4 countries 
(Argentina, China, Portugal and South Africa) compiled the Blueprint. Rhena Delport represented South Africa. A round table 
discussion was held at the Forum Meeting during which participants brainstormed on communication processes and indicators 
of effective deployment of the Blueprint in regions. This guideline will shortly be published and it will be employed not only in South 
Africa but across the continent to strengthen national initiatives to optimise STEMI care across regions.  
Adriaan Snyders chaired a session on: Regional synopsis – Where are we and what are the next steps? and Rhena Delport served 
as panel member for the STEMI Network Blueprint project.
Attendees from member countries of the 2019 Stent - Save a Life! Forum Meeting, euroPCr 
Conference, Paris, France
Stent-SAVe A LIFe!  
10tH AnnIVerSArY ForUM
Shaping the Future for SteMI Patients
May 20th, 2019
Palais des Congrè, Paris, France
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Stent – SAVe A LIFe! Project managers meeting
Rhena Delport participated as a member of the working group as national Project Manager for SASCI/ STEMI SA, and led the 
discussion on the complexities of data collection.   
Valuable insights were obtained relating to the challenges of and solutions for STEMI networks for patient referrals that the new 
member countries experience.    
SteMI India collaboration
Meetings and informal discussions were held with members from African countries as well as industry partners, during the 
Conference. The Pan-African meeting with the steering committee and international experts on systems of care for STEMI is 
depicted on the left, and on the right is a photo of the Faculty with whom STEM SA had fruitful discussions. Thomas Alexander, 
our host, stands in the centre of the group. He is co-investigator for the STEMI SA research project and has provided valuable 
input and support thus far. This is acknowledged and fully appreciated.  
education project
Standardisation of care in acute management of AcS
The Guardian initiative (Guard your Heart), which is similar to the Angles Stroke Initiative run by Boehringer Ingelheim (BI), will be 
launched shortly. It is a training programme that focusses on the management of ACS at first medical contact and results from 
joint collaboration between Emergency Physicians for Wits, STEMI SA, the Resuscitation Council, representatives from hospital 
groups, and EMS providers.   The development was supported by BI and Medtronic. 
We plan quarterly meetings in metropolitan cities, but will also make the material available to any hub hospital cardiologist who is 
prepared to arrange training sessions on a smaller scale either in their hospital or at their referral centres – provided that the user 
assists us in improving the material. We are particularly looking for case studies focusing on the time lines and correct and incorrect 
management.    
SteMI data collection 
The upgraded STEMI SA data platform will be available shortly and Dave Kettles, with the assistance of the SASCI office, will drive 
the data collection process among cardiologists in collaboration with STEMI India. Rhena Delport will continue collaborating with 
hospital groups regarding data collection and is primarily responsible for the data analysis. 
AnnUAL rePortS 2019 continued
Stent-Save a Life! 2019 Project 
Managers' Meeting, euroPCr 
Conference, Paris, France 
SteMI SA networking among faculty at 2019 CSI 
Council and SteMI India conference, Kolkata, India.
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Mapping of SteMI networks in regions
We are making progress with the process of defining a national network for referrals of STEMI patients in South Africa. Dr Eamon 
Mare will contact each Cath Lab Hospital to:
 ■  Determine who will act as contact person for the hospital at each Cath Lab hospital;
 ■  Request information to more clearly define the national network which should/could be available by determining the: 
•  Number of Cath Labs in each PCI-capable hospital;
•  Number of Cardiologists in the centre;
•  Number of Catheterisations performed per period/year ;
•  Number of STEMIs per period/year ;
•  10 Main Referral Centres and classifying whether they are a hospital/clinic/practice, emergency room or other;
•  If possible, number of STEMI patients transferred from each referral centre.
Should the requested information not be available, we will recommend/request that each Cath Lab centre reply as such and then 
collect the data required for a period of 3 months and then submit to Dr Eamon Mare. 
SteMI SA non-Profit Company (nPC) 
The present Board includes Adriaan Snyders, Rhena Delport and Len Steingo. The next Board will be elected at the beginning 
of 2021 by members actively involved in the programme. The STEMI SA NPC has opened an account and the account is 
managed by an independent accountant who will give 2-monthly feedback reports to all contributors. All financial support will 
be used for the specified purpose it was donated for, with a zero commission or handling fee.
industry members are invited to:
 ■  Register as a SUPPORTER of the STEMI SA Project with a yearly contribution of R15 000. This will be used for admin and 
local meeting expenses and a financial statement will be made available.
 ■  Contribute toward running costs (R50 000 p.a.) for the STEMI SA Software for data collection.
 ■  Adopt or participate in a metropolitan half day training session (100 attendees) or a referral site (20 - 50 attendees) evening 
training session.
 ■  Support 1 or 2 STEMI SA representatives to attend SSL and other related meetings at STEMI India; EuroPCR; ESC; AfricaPCR; 
SAHeart®; Project Managers Meeting; STEMI Africa and other Africa Meetings; and Local steering committee meetings. 
 ■  Contribute towards a SSL Africa Round Table Dinner Discussion during a SA Heart®/AfricaPCR Meeting for not more 
than 20 attendees.
 ■  Employ a research assistant for 20 hours per month for 1 year that will greatly enhance our data collection efforts.
 ■  Consider playing a major role in the STEMI SA Forum 2020 Meeting.
 ■  Discuss any options with Adriaan Snyders.
Adriaan Snyders, Champion/Chairman, SteMI SA and SSL Africa
Great savings on ESC Congress  
registration
ESC 365 — access congress slides, 
abstracts, videos — all year long
Three online ESC journals
ESC CardioMed — ESC online  
encyclopaedia
Networking &  
grants opportunities
Webinars & online courses
Join a global  
community
Meet us on the ESC Stand
www.escardio.org/Membership




   
SPeCIAL IntereSt groUPS (SIg) rePortS 
CArDIAC ArrHYtHMIA SoCIetY oF SoUtHern AFrICA, CASSA
The Cardiac Arrhythmia Society of Southern Africa (CASSA) is a special interest group of SA Heart®.
The CASSA Executive Committee consists of: Ashley Chin (president), Andrew Thornton (immediate past president), Pro 
Obel (treasurer), Adele Greyling (co-treasurer), Rob Scott Millar, Ruan Louw, 2 industry representatives (Luigi Zampieri, 
George Van Der Merwe), Human Nieuwenhuis (allied professional) and CASSA co-ordinator Glenda Nichols (nee Marcer). 
I would like to thank them for their time, expertise and support throughout 2019.
The aims of CASSA are to improve the treatment and awareness of heart rhythm disorders in sub-Saharan Africa through 
education and the facilitation of research. To achieve these goals, CASSA has been active in the following initiatives in 2019:
Annual 2019 CASSA symposia 
These popular symposia have become a regular fixture on the CASSA calendar for the past 4 years. The 2019 CASSA 
symposia took place in February and March at the Vineyard Hotel in Cape Town and the Capital Hotel in Johannesburg – over 
2 successive weekends. This year CASSA hosted 2 speakers: Professor Chris Mcleod (Mayo Clinic) and Dr Timothy Betts 
(Oxford). The symposia were entitled “Clinical Updates in Cardiac Arrhythmias”. Talks focused on paediatrics and congenital 
heart disease, atrial fibrillation (CABANA, CASTLE AF trials and device detected AF), drug therapy (anticoagulation and 
antiarrhythmic drug therapy), and device and ECG interpretation and troubleshooting. 
Planning is underway for the 2020 CASSA symposia to be held in Cape Town (29 February 2020) and Johannesburg (7 March 
2020), and 2 international guest speakers have been invited. This event is once again entitled “Clinical Updates in Cardiac 
Arrhythmias” and will be advertised at SA Heart® 2019. More details will follow in due course. 
Collaboration with the european Heart rhythm Association (eHrA)
CASSA continued to collaborate and work closely with EHRA on several initiatives over the past 2 years. CASSA was invited 
to chair a joint session with the European Heart Rhythm Association (EHRA) at the annual Europace meeting held in Lisbon 
in March 2019. I was privileged to represent a practical talk on “Differentiating typical from atypical atrial flutter on the ECG” 
at a CASSA/EHRA joint session. Dr Pro Obel gave a talk on the “Difficult atrial flutter ablation”. CASSA has once again been 
invited to chair and present 2 presentations at a joint session with EHRA on “Managing arrhythmias in the critically ill/post-
surgical patient”, at the annual Europace meeting to be held in Vienna in 2020. This will be the fourth successive year that 
CASSA has received an invitation to chair and participate in a joint session with EHRA.
CASSA has also been involved with the writing, review and endorsement of EHRA-led international scientific statements and 
guidelines. Dr Ruan Louw, Dr Pro Obel and myself were included as co-authors and reviewers of a document entitled: 
Management of asymptomatic arrhythmias: A European Heart Rhythm Association (EHRA) consensus document – endorsed 
by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac 
Arrhythmia Society of Southern Africa (CASSA), and the Latin America Heart Rhythm Society (LAHRS). It was published in 
Europace in 2019.
Collaboration with the Heart rhythm Society (HrS)
I met with the Heart Rhythm Society (HRS) at the annual Heart Rhythm Society meeting in San Francisco in May 2019. 
Opportunities for future collaboration were discussed. Dr Andrea Russo, current president of HRS, has voiced a desire for 
HRS to collaborate with CASSA at local and international meetings. 
AnnUAL rePortS 2019
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ongoing education
The quarterly ECG quiz published in the SA Heart® Journal and the 6-monthly The Andrzej Okreglicki Memorial Advanced 
ECG and Arrhythmia Interpretation Course continue to promote the teaching of ECG interpretation by cardiologists and 
cardiology senior registrars.
CASSA Accreditation
Dr Andre Saaiman was accredited as a “CASSA-accredited” electrophysiologist in 2019.
I would like to thank the CASSA corporate members for their ongoing support to the organisation. They are Medtronic, 
Vertice, Biosense Webster, Boehringer Ingelheim, Boston Scientific, Biotronik, Bayer Pharmaceuticals, and Inova Pharmaceuticals.
Ashley Chin, President, CASSA 
CArDIAC IMAgIng SoCIetY oF SoUtH AFrICA, CISSA
during the current year a number of cISSA-endorsed events were conducted:
 ■  SUNECHO echocardiography course.
 ■  New Horizon’s echocardiography course.
The yearly joint CISSA/Mayo echocardiography workshop is scheduled for the 31th of October 2019 and will feature a 
combination of speakers from South Africa, the Mayo clinic, PASCAR and ACC.
The annual Cardiovascular Magnetic Resonance Congress of South Africa (SA-CMR) will be held in conjunction with the 
SA Heart® meeting, from 31 October - 3 November 2019.
CISSA has acquired additional sponsorship and all members should be on the lookout for upcoming applications for sponsorship 
to imaging congresses.
Alfonso Pecoraro, President, CISSA
HeArt FAILUre SoCIetY oF SoUtH AFrICA, HeFSSA
The Heart Failure Society of South Africa (HeFSSA) has several programmes planned to ensure that we achieve our goals for 
the society in 2019. 
HeFSSA executive 
The HeFSSA Executive is the driving force behind these programmes: Martin Mpe (President), Eric Klug (Ex-Officio President), 
Jens Hitzeroth (Vice-President), Darryl Smith (Treasurer), Nash Ranjith (Secretary) and Karen Sliwa, Len Steingo, Tony Lachman, 
Makoali Makotoko, Nqoba Tsabedze, Ntobeko Ntusi and Mpiko Ntsekhe, with George Nel (Executive Officer). 
This year saw the active engagement of the government on issues such as expanding Heart Failure medication on EDL and 
updating the public sector treatment algorithm. The National Department of Health also assisted with distributing invitations 
to HeFSSA GP meetings in the various centres. HeFSSA plans to expand this collaboration.  
HeFSSA HF guideline and treatment Algorithm  
The HeFSSA HF Guideline and Treatment Algorithm reflects the current best practice and is based on the published ESC 2016 
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Guidelines, recent landmark publications, and South African clinical experience. We submitted the Update Guidelines and 
Treatment Algorithm to the SA Medical Journal and hope to see publication in 2019.  
research 
HeFSSA HF Clinical Snapshot Survey is planned for the first half of 2020. Makoali Makotoko is spearheading this initiative 
which we will launch nationally and hopefully it will become an annual audit of HF in South Africa – allowing us to reflect year-
on-year and in due course over extended periods. This survey could ultimately inform resource alignment and investment in 
HF networks.  
educational grants 
HeFSSA has put in place a process to manage educational grants through the society’s infrastructure and has been able to 
support the attendance at ESC Congress 2019 of practitioners with a special interest in heart failure. This was made possible 
through educational grants from Medtronic and Boston – with 2019 beneficiaries being Blanche Cupido, Riette du Toit and Luke 
Hunter. HeFSSA also offers Educational Travel Awards with a total value of R70 000 per annum (maximum of R35 000) to 
support attendance of heart-failure related meetings and congresses. This funding will, in 2019, be used to support attendance 
of the SA Heart® Congress and a formal grant application process will be followed.  
HeFSSA Medical Practitioners’ Programme 
The HeFSSA Medical Practitioners Programme (primarily GP) continues to be of great value to the medical community and is 
the main vehicle we use to achieve our heart failure educational goals. The programme started in 2010 and saw more than 540 
GPs attend in 2018. We offer the course annually and have established it in both metropolitan and rural areas. This programme 
is in its ninth consecutive year and continues to be generously supported by Servier, Pharma Dynamics and Novartis. 
the theme for 2019 is “challenges in Heart failure Management” and the topics being addressed are:
 ■  Dyspnoea and leg swelling, when is it heart failure?
 ■  Management of acute decompensated heart failure
 ■  Heart failure during pregnancy
 ■  Refractory oedema in heart failure patients
The case-based slide compendium for this year’s programme has been compiled by Jens Hitzeroth, Nqoba Tsabedze, Karen 
Sliwa and Ntobeko Ntusi. The faculty members include a distinguished South African cardiologist with an interest in heart 
failure from across South Africa. This year’s meetings will be hosted across South Africa and Namibia as follows:
15 June Ongwediva, Namibia 13 July  Windhoek, Namibia
17 August Polokwane, Fusion Hotel 31 August George, Fancourt
7 September Johannesburg, Silvasales  14 September Nelspruit, Protea Hotel 
 Wanderers Restaurant 
28 September Swakopmund, Namibia 28 September Mthatha, Hotel Savoy
5 October Port Elizabeth 5 October Mahikeng
12 October Kimberley, Protea Hotel 18 October Bloemfontein, Leopard & Lace
19 October East London, Lord Selbourne 19 October East Rand, Birchwood Hotel 
26 October Somerset West, Edenvale Estate 9 November Pretoria, Casa Toscana  
16 November Cape Town, Crystal Towers 23 November Durban, Riverside Hotel
30 November Tzaneen, Hotel @ Tzaneen




Cardio update for non-Cardiologists 
HeFSSA will be involved in the SA Heart® Congress 2019, at Sandton Convention Centre. All the HeFSSA members are 
requested to attend the HeFSSA sessions – as well as the AGM. HeFSSA continues to invest in education by hosting the 
annual Cardio Update for Non-Cardiologists. The pre congress workshop will take place on Thursday, 31 October, from 
12:20 - 17:00 – with Len Steingo and Nqoba Tsabedze as the programme convenors. We expect more than 100 medical 
practitioners to attend the meeting. This meeting is made possible by support from Boehringer Ingelheim, Servier and Novartis.
HeFSSA is supported by loyal corporate members committed to education in heart failure. Our sincere appreciation goes 
to Boston Scientific, Boehringer Ingelheim, Medtronic, Pfizer, Pharma Dynamics, Servier, Vertice, Biotronik, and Novartis for 
continued support. 
The HeFSSA website is continually updated to remain relevant. Please visit the website at www.hefssa.org and contact the 
HeFSSA office to make contributions and to ensure that the items stay updated and relevant.
HefSSA encourages all parties who want to be involved in heart failure to contact george Nel, HefSSA executive Officer 
at info@heffsa.org. 
Martin Mpe, President, HeFSSA
SoUtH AFrICAn SoCIetY oF CArDIoVASCULAr InterVentIon, SASCI
This will be my final report as President, and I would like to thank my executive committee for their unwavering support and 
our Industry partners for their continued professional engagement and generosity in times of change and challenge. 
SASCI executive Committee (term ending AgM 2 november 2019) 
D. Kettles (President), F. Hellig (Ex-officio President), H. Weich (Vice-President), C. Badenhorst (Treasurer), G. Cassel 
(Secretary), J. Vorster (SASCI PPC Chair), S. Khan, G. Angel, M. Ntsekhe, M. Makotoko, A. Vachiat, C. Zambakides, G. Angel, 
S. Pandie, J.P. Theron and W. Howell (ISCAP). 
ISCAP
Waheeda Howell (Chair) and her team continue with their stellar work focusing on Allied education (separate report). 
SASCI Positioning Statement 
Shockwave Therapy (February 2019)
SASCI Private Practice Committee 
I would like to thank Jean Vorster for his leadership of the SASCI PPC which is also home to the SA Heart® PPC and 
contact point with SIGs, such as CASSA. The group consists of: David Jankelow, Andrew Thornton, Dave Kettles, Gavin Angle, 
Graham Cassel and George Nel, with an open invitation to others to contribute. I would like to thank Dr Tom Mabin for 
his willingness to actively work with SASCI PPC. Please see separate SASCI PPC report. 
As President I have frequently been engaged by funders, particularly in the last months, on a range of issues. In a multitude of 
contexts there have been many opportunities to represent, to the best of my abilities, our position as cardiac interventionists. 
It is encouraging to see that our SIG has clearly established itself with the right and credibility to communicate on behalf of 
our members with many who wish to solicit a representative voice in the cardiology community. 
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SASCI educational 
Initiatives continue to be a cornerstone activity. Highlights of the educational initiatives SASCI has been, and continues to be, 
involved in include:
Master the Complex 2019 
SASCI and PASCAR was involved in the Boston Scientific Master the Complex 2019 session in Johannesburg on 25 and 
26 January 2019. This year, 60 cardiologists attended the meeting including delegates from South Africa, Mauritius, Kenya, 
Sudan and Namibia. Drs Simon Walsh and Julian Strange featured as international faculty and they were supported by well-
respected South African and sub-Saharan African interventional cardiologists. The programme was developed under the 
guidance of Dave Kettles, Farrel Hellig and Awad Mohamed (Sudan). The meeting provided cardiologists with training on 
new trends in complex interventional procedures, technologies and troubleshooting through interactive talks and live cases.
SteMI Africa Live! 2019 
SASCI and PASCAR supported the development of African Cardiology in Nairobi, 26 - 27 April 2019 with Dave Kettles, 
Adie Horak and Justiaan Swanelvelder as part of the South African faculty and Zimasa Jama (Groote Schuur Hospital) as 
case presenter. 
euroPCr 2019 
SASCI, with support from Medtronic and Boston Scientific, ensured that cardiologists on faculty received educational grants. 
The recipients were Arthur Mutyaba, Jens Hitzeroth, Michael Dean and Marshall Heradien. 
endovascular Cardiac Complications Congress 2019 
ECC 2019 was held in Lausanne, Switzerland from 26 June - 28 June. Dave Kettles represented SASCI, giving a keynote lecture 
during the congress.  
SASCI VPP 
The SASCI Visiting Professor Programme is a well-established initiative and an annual highlight on the SASCI calendar. 
Prof Simon Redwood, professor of interventional cardiology and honorary consultant cardiologist at Guy’s and St Thomas’ 
NHS Foundation Trust, has accepted our invitation to travel to South Africa as the Visiting Professor for 2019. 
Prof Redwood payed a visit to the Gauteng and Free State Medical Schools in July 2019 and will be back in South Africa from 
30 September 2019 - 2 November 2019 to attend the SA Heart® conference, AfricaPCR course and visit the coastal Medical 
Schools. Prof Redwood works hands-on in the cath lab along with fellows and consultants in addition to presenting multiple 
lectures at each unit. The SA Heart® Branch and SASCI Evening Lectures initiative is also a great success attracting delegates 
from Bloemfontein (52), Johannesburg (52) and Pretoria (57). 
We look forward to welcoming Dr Greg Barsness from the Mayo Clinic, Rochester, USA who accepted our invitation to travel 
to South Africa as Visiting Professor in 2020. 
Multiyear support received from Medtronic and Pharma Dynamics enables this programme. 
Annual Fellows Workshop 
SASCI hosted the 15th Annual Fellows Workshop in Sandton on 17 and 18 August 2019. The meeting was a great success 
with interactive and robust discussions and debates between the faculty and fellows. A total of 48 practitioners attended the 
workshop, including 2 fellows from Kenya and 2 from Mauritius. We hope to expand our SSA delegate contingent in 2020 to 
make this a truly African Fellows training and networking event.  




Jean Vorster and Graham Cassel once again took the lead and developed an exceptional programme that was well supported 
by an extensive faculty including: Gavin Angel, Dave Kettles, Sajidah Khan, Adie Horak, Farrel Hellig, Ahmed Vachiat, Jacques 
van Wyk, Mark Abelson, Chris Zambakides and Pieter van Wyk. James Fortein (UFS) and Hanneke Danheimer (WITS) won the 
best-case presenter’s award and received free registration to attend the AfricaPCR Congress 2019, sponsored by SASCI.
SASCI are hugely indebted to industry who have continued to generously support this annual programme: Biotronik, B Braun, 
Boston Scientific, Disa Vascular, Paragmed, Siemens, Baroque, Vertice Healthcare, Terumo. Meril Cardiology, Merit Medical, 
Medtronic and Torque Medical were all involved this year.
Boston rC Fraser International Fellowship 
Annually, SASCI sends a fellow, for a period of up to one month, to gain valuable experience at Prof Simon Redwood’s unit 
at Guy’s and St Thomas’ Hospital, London. In 2018 the incumbent was Dr Portia Moses (UFS). Call for Nominations for 2019 
will open soon. 
tCt 2019 
Transcatheter Cardiovascular Therapeutics (TCT) is a large scale American meeting with a very noteworthy reputation. Under 
convenorship of Graham Cassel, Drs Sajidah Khan, Mfundo Mathenjwa and Mpho Sebesho will be attending. SASCI is happy 
to once again support a group of RSA Cardiologists. 
AfricaPCr 2019 
The SASCI Grant application portal is open (from mid-August) with confirmation to applicants on 20 September. In 2018, 
SASCI supported 59 delegates, including 24 fellows, to attend AfricaPCR. We hope to increase this number in 2019. 
Fellows Course at Columbia University nYC 
In 2018, SASCI selected 3 fellows to attend the Medtronic Fellows Course at Columbia University New York City for the first 
time. They were Kwena Komape-Makgato (Chris Hani Baragwanath Academic Hospital), Menachem Levin (Charlotte Maxeke 
Johannesburg Academic Hospital) and Deya Ramachandran (Inkosi Albert Luthuli Central Hospital).
The next Course will take place from 7 - 9 February 2020 in New York. Call for nominations open on 9 September 2019. 
Medtronic supports this course on a turnkey basis. 
SteMI SA 
Dr Adrian Snyders and Prof Rhena Delport have done a huge amount of work for this project. Data collection for a national 
registry has just started at Life St Dominic’s Hospital and is about to start at a number of other hospitals as well. We want 
to capture a cross section of current management of STEMI and provide data which everybody always notes does not exist. 
If any colleagues wish to be involved in this project, Dr Kettles eagerly awaits your declaration of interest. Educational Work-
shops have been and will continue to be arranged to assist those who wish to strengthen STEMI care in their region. 
new Proctorship Programme in 2019 - SASCI Visiting expert Programme 
SASCI, in partnership with Vertice Healthcare, is launching a new Visiting Expert Programme with a focus on proctorship in 
Complex PCI procedures. Prof Tony Gershlick, consultant Cardiologist at Leicester’s Hospital and Honorary Professor of 
Interventional Cardiology at the University of Leicester, will be the first Visiting Expert travelling to South Africa in 
November 2019. Prof Gershlick will proctor cases as they present on the day with a focus on bifurcation and other complex 
PCI procedures. We trust that this new initiative will become an annual initiative. 
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Society for Cardiovascular Angiography and Interventions Fall Fellows Course 
With support from SCAI and Boston Scientific, SASCI supported 4 South African fellows to attend the SCAI Fall Fellows 
course in December 2018 (Aveen Mahabal, Robert Leibbrandt, Mmuso Mogwera and Absalom Nkosi). The 5 2019 recipients 
are Ndikondisene Tshiovhe, Ashandren Naicker, Zimasa Jama, James Fortein and Jerry Chen. They will travel to Las Vegas in 
December 2019 for a week’s training. 
oUtgoIng PreSIDent note 
It has been my privilege, and for the most part a joy, to be president of this organisation for 4 ½ years. It was never intended 
to be a marathon: naively I expected a 2-year stint. However, this period has been greatly enriching, and I believe in these years 
SASCI has continue to build on solid foundations to become a vibrant and contributing member of the medical society 
landscape. Right now we find ourselves in uncertain, even perplexing times. Rumours of change, and many challenges, yes. 
But I have no doubt that innovative solutions are out there for us to discover, and our members will continue to adapt, to 
learn, and to grow, so that we can continue to provide contemporary, excellent therapies to our patients. Let us not just 
“stay in touch” with the world: let us mature into leaders and pioneers in the interventional community worldwide.
At the 2019 AGM we will choose new leadership. I wish my successor a time of useful contribution as he or she puts their 
personal touch on the future activities of this society. I have no doubt that SASCI will thrive in the future – the contributions 
required from us to maintain and promote the discipline of interventional cardiology are too great for us to even consider 
faltering.  
I extend my deepest gratitude to George and to his team: they serve our society with excellence and commitment. No 
hours are after hours. Nothing I have ever done at SASCI has been done without their unwavering support at every level. 
I thank all my friends in the industry: so many of you betray any stereotype of heartless profit driven businesspeople: you 
have shown serious commitment to education, to skills development and career path promotion for young colleagues. You 
have put substantial amounts of funding into projects whose only goal is to make us better interventionists, who can better 
serve our nation? Many of you have become my friends. Thank you.
As I step down, I salute you all. May your skills and contributions continue to grow, may you continue to find fulfilment in this 
most stimulating and privileged of careers that you have built for yourself. Let us be purposeful givers to the health of our 
nation and always strive for excellence as we serve our patients’ needs first. 
My life has been enriched and enlarged during the time I have served SASCI. I thank each of you for that.
Dave Kettles, President, SASCI 
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SASCI PrIVAte PrACtICe CoMMIttee
The SASCI PPC (including SA Heart®) under the leadership of Jean Vorster initiated the process of developing a CPT cross 
walk. The PPC contracted Karen van der Westhuizen to assist with the cross walk together with David Jankelow, Andrew 
Thornton and Dave Kettles. We would like to thank Dr Tom Mabin for his willingness to actively work with SASCI PPC to address 
various issues, including consulting on CPT coding and funder engagements. Meetings have been set up with SAMA and major 
funders as part of the process.  
SASCI PPC has been involved in addressing coding “issues” raised by, for example, Discovery Health (practice audits) and Medihelp 
on behalf of our members as well as the issue of Vascular Codes not being reimbursed. Members are requested to bring issues 
to our attention to allow us to minimise the impact on your individual practice.
Elsabe Klinck Associates is on a retainer to advise on ongoing legal, statutory and policy matters, including submissions on the 
HPCSA Global fee issue, CMS PMB process, HMI Outcomes Measures, TAVI Medihelp, and HMI Tariffs. A major focus area going 
forward will be the National Health Insurance. Please see the separate report from Elsabe Klinck.
Update on Law, regulation and Policy in the health sector (18 September 2019)
The following matters occurred in the period from April 2019 and merit consideration by all practitioners:
Update on tAVI / tAVr
Bestmed Medical Scheme: Bestmed funded the member in full at cost for all expenses incurred. The payment was made to the 
member’s bank account as an ex gratia payment. Bestmed still insists that the initial funding decision was correct. However, they 
settled the payment as a way forward and that this act of kindness should not be regarded as precedent setting.
Bonitas Medical Scheme: Post the initial full decline of payment toward the entire TAVI procedure, Bonitas changed the funding 
decision and funded the claim up to an alleged cost of SVR. However, Bonitas still maintained a prosthesis limit of R50 000. 
It therefore entailed that, the biggest part of the claim, the TAVI, was regarded as a prosthesis. The cost of TAVI was approximately 
R299 000, leaving the member with an almost R250 000 co-payment. EKA approached once again, the office of the Principal 
Officer, currently being Mr Lee Callakoppen. We understand that the claims have been sent for a second opinion to Dr Ivan 
Sherwood, a cardiologist. We await feedback accordingly and will update once it is received. Armed with the Registrar’s Ruling as 
per below, we will approach the office of the Principal officer once more, should the claims be declined.
Medihelp Medical Scheme: The long-awaited Ruling of the matter between SASCI and Medihelp Medical Scheme was received 
from the Registrar of the Council for Medical Schemes on 11 September 2019. The Ruling was in favour of SASCI. The crux of 
the matter was that Medihelp was unlawfully limiting the funding of TAVI procedures in respect of patients suffering from Aortic 
Valve Stenosis, which is a Prescribed Minimum Benefit (PMB) condition. The said funding limitation is implemented by way of a 
prosthesis limit on TAVI for all members registered on all of Medihelp’s benefit options, and, by so doing, Medihelp members could 
not access the full PMB benefit they were entitled to.
The Registrar ruled that the use of benefit option rules and vascular prosthetic limits to curb Medihelp’s funding liability in 
TAVI procedures is “found to be offensive to the Act and the Regulations in that it is both restrictive”.
Whilst this is a victory to be celebrated, EKA is cognisant of the fact that Medihelp has 90 days from 11 September 2019 within 
which to lodge an appeal to the Appeals Committee challenging the decision of the Registrar. Once Medihelp has lodged 
the Appeal, the decision of the Registrar will be suspended. This lodging of an appeal (s48 of the Medical Schemes’ Act), will 
suspend the order by the Registrar that Medihelp must, within 90 days of the date of this ruling, align its rules and funding 
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model for TAVI procedures with the Mabin Appeal Board ruling to ensure that it funds the average cost funded for open heart 
procedures, inclusive of all the necessary components applicable to the PMB entitlement. The appeal will have the effect that, 
Medihelp will not be obligated to implement the remedial actions requested by the Registrar. 
EKA has arranged a meeting between SASCI and Dr Lee Moses from Medihelp on 15 October 2019. EKA seeks to probe 
Dr Moses in order to gather intelligence on whether Medihelp seeks to appeal the decision of the Registrar. However, the final 
decision will be noted post the expiry of the appeal period. EKA will closely monitor the events herein and update accordingly.
nHI Bill, 2019
The NHI Bill has been introduced in Parliament, and will now follow parliamentary processes – namely a call for comments by the 
Portfolio Committee on Health, followed by verbal presentations. There will also be provincial processes, whereby provincial 
parliaments will obtain input from the public to inform their mandates sent to the National Council of Provinces, which will also 
deal with the Bill.
It is important that practitioners look at the implications of the Bill for themselves, and their patients. These are, from our point of 
view, largely practical, i.e. relating to what is indeed possible, and what is feasible in the short, medium and longer term.
the Bill envisages a re-organisation of the public and private healthcare sectors: 
In the public sector, all regional, tertiary and central hospitals will no longer fall under provinces, but under the National Department 
of Health (NDoH). This would include academia, and will be complex from constitutional and labour law perspectives, as health 
science facilities and medical schools, which are in part governed by the specific university’s Act, and in part by labour law with the 
specific province as the employer, but also the entity that sets availability of types of care. Hospitals are described as “semi-
autonomous” for central hospitals (with cost centres) and “autonomous legal entities” for regional and tertiary hospitals. Hospitals 
will get budgets from the NHI Fund (“NHIF”) based on diagnosis-related groups (DRG) for the population it serves.
Primary healthcare will be organised in so-called “Contracting Units for Primary Health Care” (“CUPs”) – being subject to 
oversight by District Health Management Offices (“DHMOs”), which will also not be part of the provinces, but form a 
“component” of the NDoH. The DHMOs will also be responsible, through an amendment to the National Health Act, for 
the District Specialist Support Teams, although the relationship with, or in the NHI, is not clear (e.g. will the capitated fee paid 
to the CUPs include the work of the District Specialist Teams?).
There is very little in the Bill on the details around private sector specialist care, and how its re-organisation is expected to take 
shape. The Bill states that the NHIF will contract CUPs, emergency services and “hospitals”. Under the payment clause, it 
merely states that payment for specialist and hospital services must be “all-inclusive and based on the performance of the 
health care service provider, health establishment or supplier of health goods”. Although providers will not claim from the NHIF 
in the way one does from a medical scheme, the Compensation Fund or RAF, providers are expected to stick to the “national 
pricing regimen” for services. It is not clear when this will, in fact, apply.
There will be an Office of Health Products Procurement (“OHPP”), which will facilitate the procurement of “high cost devices 
and equipment”. All procurement must be done in line with the OHPP’s Formulary, which will be based on the Essential 
Medicines List (EML) and the Essential Equipment List (EEL). It is unclear how existing equipment in practices, which may not be 
included in the EEL, will be handled. As a condition of contracting, practitioners will be expected to adhere to the Formulary. 
Mention is made of a “complementary list”, which will have to be approved by the Minister of Health. Unlike the Medical 
Schemes Regulations, which requires formularies and protocols to be set on the basis of evidence-based medicine, and for 
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exceptions to be made for deviations from those in cases of ineffectiveness in treatment, harm or potential harm, and adverse 
effects, no such principles appear in the NHI Bill. 
The most controversial aspects of the NHI, and not addressed in the Bill, relates to the funding of the system (“money in”), and 
the payment of providers (“money out”). The National Treasury paper on the funding of the NHI is still awaited.
Although the shifting of funds from medical scheme contributions through a special payroll tax will lead to an increase in the pool 
of money available to the NHIF, and increase the amount available per patient per annum in the public sector, the annual amount 
available for a patient who was, but no longer can afford, medical scheme cover will be significantly less. This assumes that there is 
a possibility to, through increased volume, lower pricing of all services and goods in the private sector. It is unclear whether 
the willingness and feasibility of industry-wide price reductions have been modelled. Particularly pertinent is the fact that basic 
practice costs (e.g. salaries, rental, already-procured goods and equipment) will not change, unless there is a large-scale physical 
and structural re-organisation in practices. 
the davis tax committee, in March 2017, found as follows in relation to the feasibility of the NHI:
Given the current costing parameters outlined in the White Paper, the proposed NHI, in its current format, is unlikely to be 
sustainable unless there is sustained economic growth.
There are also aspects on which the NHI Bill is silent, such as the role of the NHLS and private pathology, the provision of blood 
and blood products by SANBS, research and development (and post-trial access). It is also not clear how provincial departments 
of health debts and liabilities, e.g. for malpractice lawsuits and unpaid suppliers, will be handled in the transition into an NHI system. 
the PMB review
In spite of uncertainty as to the exact nature of the “complementary cover” medical schemes would be able to provide under the 
NHI, and the certainty that the NHI will provide primary care (PHC), the CMS is pressing ahead with the inclusion of a PHC 
portion to the PMBs. The process is currently with a priority-setting committee, to engage on the draft PHC package that was 
issued earlier this year.
Dr Kabana, Registrar of the CMS, said in an interview on Business Day TV, that as benefits are included in the NHI, they will be 
removed from medical scheme cover. Practically, it would be difficult for a patient to enter the NHI system, receive professional 
services and to then exist again to access, for example, innovative technologies not available in the NHI. 
Section 59 Inquiry 
The CMS has initiated an inquiry into allegations of racial discrimination during the conduct of medical scheme forensic inquiries 
(section 59’s). Although there has been mixed reaction as to whether there is indeed racial profiling, there was remarkable 
commonality in the testimonies of provider groups and advisors on how forensic investigations are undertaken. One of the key 
matters raised, was the lack of common understanding on the coding system, and that it creates room for claw-backs to occur. 
Such coding issues do not necessarily mean that fraud had been committed.
Jean Vorster, Chairman, SASCI Private Practice Committee
Update on Law, regulation and Policy in the health sector provided by elsabe Klinck and Associates 
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InterVentIonAL SoCIetY oF CAtH LAB ALLIeD ProFeSSIonAL, ISCAP
As part of ISCAP’s dedication to you as the Allieds, we are focussed on your needs and have structured the ISCAP organisational 
model to ensure you are represented through various channels. Your voice is important to us – so please do engage with 
regional or national committee members. 
I would like to thank my Committee and Co-opted members for their continued contributions. 
gauteng 
Isabel Bender (Vice Chair Nurses as well as Regional Chair), Kerry Moir (Radiographers), Jamie-Leigh Hayes (Technologists) 
and Ramabai Zwapano (Nurses).
western cape
Carmen November (Regional Chair), Sabira Khatieb (Radiographers), Human Nieuwenhuis (Technologists) and Maggie 
Petersen (Nurses).
KwaZulu-Natal
Selvan Govindsamy (Regional Chair), Amit Singh (Technologists) and Don Pardechi (Nurses).
free State
Marlet Bester (Technologists)
Thanks are due to Marisa Fourie whose term ended in 2018. Your continued guidance and support are appreciated. I am 
certain you will continue to play a major role through the upcoming 2019/2020 ISCAP Lecture Series, as your knowledge and 
expertise is of great value to ISCAP.
eastern cape
Keri Meyer (Regional Chair), Ronelle de Glanville (Radiographers), Elzanne Oosthuizen (Technologists) and Naomi 
Oosterbroek (Nurses).
co-Opted for education & cath Lab Manual
Gill Longano
ex-Officio chairperson and cath Lab Manual
Dianne Kerrigan 
SA Heart® & AfricaPCr grants 2019
The AfricaPCR Course and SA Heart® Congress remain as seminal educational contact points receiving substantial Exco time 
and effort to optimise the learning.  
The SASCI Office is continuously approaching industry for educational grants to support the allied professionals to attend the 
upcoming joint SA Heart® & AfricaPCR Congress.
We look forward to AfricaPCR 2019, where we hope to raise more funding for sponsorship.
Continued on page 282
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ISCAP national Lecture Series 2019
ISCAP is focussed on ongoing training for all Cath Lab Allieds including nurses, radiographers and technologists across 
South Africa. We had a roaring start to 2019, with Lecture Series starting in January! ISCAP would like to thank you for 
supporting these lecture meetings and thus contributing to the excellence we believe every Cathlab should maintain, as well 
as conveying knowledge to our fellow colleagues.
As an added bonus, ISCAP have handed out a different coloured ISCAP SASCI Branded Cathlab Buff with each series. These 
buffs are to increase the visibility of the Society’s involvement in the Cathlab and the commitment to ongoing training and 
education.
the Lecture Series consists of the following topics: 
 ■  Distal Radial Access.
 ■  Uterine Fibroid Embolisation.
 ■  Prostatic Artery Embolisation.
cPd Accredited for 3 Standard ceUs through the University of Pretoria:
26 January: cape town  66 Allieds in attendance  16 february: durban  52 Allieds in attendance
2 March: Midrand   62 Allieds in attendance  11 May: Port elizabeth  28 Allieds in attendance
20 July: Bloemfontein  29 Allieds in attendance
During this series, the allieds had the privilege of listing to Drs Darren Klass, Michelle Da Silva, Werner van Straaten and 
Prof Samia Ahmad. 
A special thank you to Jolanda Clifton and Scott de Oliveira from the Merit Medical for sponsoring this lecture series. 
Their commitment to education has given 237 allied professionals the opportunity to engage on these topics, so furthering 
their education.
ISCAP terumo Vertice Series 2019
the Lecture Series consists of the following topics: 
 ■  ESC/EACTS Clinical Practice Guidelines.
 ■  Treatment of High Bleeding Risk Patients.
 ■  Bio-Ethics: Walk a mile in my shoes.
cPd Accredited for 2 Standard and 1 ethics ceU through the University of Pretoria:
11 May: durban 30 Allieds in attendance 18 May: Midrand 45 Allieds in attendance
1 June: cape town 64 Allieds in attendance  24 August: Port elizabeth 30 Allieds in attendance
 7 September: Bloemfontein 19 Allieds in attendance
During this series, the allieds had the privilege of listing to Dr Lutchman, Dr Mamdoo, Dr Peterson, Dr Hitzeroth, Dr Hassan 
and Dr Butua. A special thank you to Sr Lucia Van Heerden who flew to all the workshops to present the Bio-Ethics topic and 
to share her life story. 
282 283
   
A special thank you to Vertice Medtech and Terumo for sponsoring this lecture series, and for their teams going the extra mile 
to further education in the Cathlab.
ISCAP Boston riverdene Siemens Series 2019
the Lecture Series consists of the following topics: 
 ■  Stuck between a rock and a hard place: Rotational atherectomy overview.
 ■  Contrast indications – More than basics.
 ■  Ethics of artificial intelligence in health care.
cPd Accredited for 2 Standard and 1 ethics ceU through the University of Pretoria:
16 March: Port elizabeth 39 Allieds in attendance  6 April: Bloemfontein 28 Allieds in attendance
8 June: durban 92 Allieds in attendance 20 July: Midrand 53 Allieds in attendance
3 August: cape town 78 Allieds in attendance
During this series, Drs van der Merwe, Visagie, McKibbin, Van Zyl and Horak presented on Rotational Atherectomy. Dr Ashesh 
Ranchod and Sinal Govender flew to each of these workshops to present on Contrast Indications and the Ethics of using 
artificial intelligence in the Cathlab, respectively.
Thanks are due to Boston Scientific, Riverdene and Siemens for sponsoring this lecture series. Their respective field force 
made this series possible, ensuring that 290 allied professionals were given the opportunity to engage on these topics, so 
furthering their education.
ISCAP Catheterisation Manual
Dianne Kerrigan and Gill Longano have worked tirelessly to update the ISCAP Cath Lab Manual online version, as well as the 
development of additional chapters. The first of these are currently available and are CPD Accredited:
Module 1: 
 ■  The Historical Developments of Coronary Angiography 
 ■  Cardiac Anatomy and Physiology 
 ■  Basic ECG Interpretation 
 ■  Coronary Pathology
Module 2:
 ■  The Roles and Responsibilities of the Cath Lab Team 
 ■  Indications and Contraindications for Coronary Angiography 
 ■  Basic Concepts in Cardiac Catheterisation 
 ■  Asepsis in the Cardiac Catheterisation Laboratory
Both these manuals are available on the Boston Educare Platform and are linked to a CPD Questionnaire. To view the 
Modules and to complete the CPD Questionnaires, visit sasci.co.za.
Continued on page 284
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Thanks are due to Boston Scientific for their help in developing the ISCAP Manual – to hopefully reach more allieds though 
an online platform.
We thank our Corporate Support for their continued and unwavering support of ongoing education in the Cath Lab. If you 
require more information regarding the topics and other information for the above workshops, kindly contact the IScAP 
Office at joh-ann.nice@medsoc.co.za.
Waheeda Howell, Chairperson, ISCAP 
LIPID AnD AtHeroSCLeroSIS SoCIetY oF SoUtHern AFrICA, LASSA
The Lipid and Atherosclerosis Society of Southern Africa (LASSA) remains affiliated with both the Society for Endocrinology, 
Metabolism and Diabetes of South Africa (SEMDSA) and the South African Heart Association (SAHA). LASSA is also linked 
to the International Atherosclerosis Society (IAS).
The LASSA committee members, working in academic institutions, endeavour to sustain expertise for medical practitioners, 
scientists and the public. The committee is led by Prof David Marais assisted by Prof Derick Raal as secretary and treasurer, 
Dr Dee Blackhurst, and Prof Dirk Blom. Support for developing lipidology at any of the health science faculties remains lacking, 
despite the increasing recognition of common disorders such as familial hypercholesterolaemia (FH) and other serious disorders 
that deserve diagnosis and specialised management. Since LASSA is a small organisation and has limited expenses, its finances 
remain intact. The funds are intended for supporting meetings involving education as well as special investigations that may be 
required for patients. The constitution will be reviewed to ensure best function.
Dedicated lipid clinics for patients with severe dyslipidaemia remain only in Johannesburg and Cape Town. Since neither the 
National Health Laboratory Service (NHLS) nor private pathology laboratories provide special investigations for these severe 
disorders, laboratory investigation of complex problems remains limited to the laboratory in Cape Town where funding and 
staff are limited.
In March, LASSA hosted a lipidology course for 22 delegates – mostly young internal medicine specialists. It was based on the 
course held in the previous year for a group of Dutch vascular medicine specialists. The meeting was supported by educational 
grants by Amgen, Sanofi, MSD and Cipla. Pathcare and Lancet laboratories also supported the course.
Two newsletters were circulated. The first summarised the course and the second was an update from the European 
Atherosclerosis Society (EAS) congress in Maastricht from 26 - 29 May.
It is important that LASSA and other organisations raise awareness of FH, which is receiving worldwide attention. Off-patent 
Ezetimibe will hopefully become available in South Africa for severe dyslipidaemia. The monoclonal antibody neutralisers of 
PCSK9 have been under review at the South African Health Products Regulatory Agency (SAHPRA) for a few years and have 
still not been approved. The neglect of support for the diagnosis and treatment of lipid disorders – especially for FH the 
commonest severe autosomal dominantly inherited disorder – will hopefully be corrected by the National Health Insurance.
Derick raal, Secretary, LASSA
AnnUAL rePortS 2019 continued
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SoUtH AFrICAn SoCIetY For CArDIoVASCULAr reSeArCH, SASCAr
The South African Society for Cardiovascular Research (SASCAR) – an interest group of the SA Heart® Association – was 
created in October 2009. 
The SASCAR Executive Committee elected in September 2016 is: Prof Neil Davies (Chairperson), Dr Derick Van Vuuren 
(Secretary), Prof Sandrine Lecour (Treasurer), Prof Faadiel Essop, Prof Karen Sliwa, Dr Balindiwe Sisi, and Dr Wayne Smith. 
Workshops
cardiac function workshop
A critical area for all cardiovascular students is the understanding of the complexities of cardiac function. For this reason, 
SASCAR was very pleased to be able to hold a workshop on this topic in conjunction with LASEC, a supplier of specialist 
laboratory equipment. The workshop explored cardiac pressure loops generated using microcatheter-generated cardiac 
pressure data derived from a hands-on demonstration by a technique expert from ADI, Australia, who was ably assisted by 
the UCT Health Faculty veterinarian, Dr John Chipangura. The workshop was held at UCT and was well attended and received 
by staff and postgraduate students.
the 4th europe-SA cardiovascular Research workshop 
The year 2019 for SASCAR was dominated by the 4th Europe-SA Cardiovascular Research Workshop organised by 
Prof Lecour (UCT). Following on the success of our previous joint Europe-South Africa meetings held in London (2010) and 
Cape Town (2012, 2016), SASCAR held the 4th Europe-SA Cardiovascular Research Workshop in STIAS, Stellenbosch, 
South Africa, from 1 - 5 April 2019. This was in conjunction with the international 6th Frontiers in cardiovascular research 
meeting. 
The aim of these meetings is to promote interaction and research training between European and South African students and 
researchers. Seven European students (late PhD) were looked after by a group of South African postgraduate students, and 
spent 2 and half days of the week visiting cardiovascular research facilities at the University of Cape Town and University of 
Stellenbosch, in-between cultural and social activities. An extra 2 days was dedicated to lectures at STIAS, Stellenbosch, which 
were attended by 95 delegates. Postgraduate and established researchers from various South African institutions were given 
Workshop participants viewing 
catheter insertion
Left to right: Prof Klaus Preissner, Prof Sandrine 
Lecour, Dr Hector Cabrera Fuentes and  
Prof Derek Hausenloy
Continued on page 286
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AnnUAL rePortS 2019 continued
the opportunity to present their research and network with 23 prestigious international speakers in the field of cardio- 
vascular research, who contributed to the meeting and presented their work in various areas of cardiovascular research:
Ioanna Andreadou (Greece); Eveline Baumgart-Vogt (Germany); Robert Bell (UK); Juergen Bernhagen (Germany); William 
Boisvert (Hawaii); Hector Cabrera-Fuentes (Singapore); John Cunningham (UK); Sean Davidson (UK); Fabio di Lisa (Italy); 
Felix Engel (Germany); Fulvia Ferrazzi (Germany); Derek Hausenloy (Singapore); Thomas Krieg (UK); Rosalinda Madonna 
(Italy); Karlheinz Peter (Australia); Klaus Preissner (Germany); Daniel Sedding; Manvendra Singh (Singapore); Carl Vogel 
(Hawaii); Malcolm Walker (UK); Derek Yellon (UK); Paul Yen (Singapore); and Coert Zuurbier (The Netherlands).
SASCAR aims to have a workshop in the next quarter on pre-clinical in vivo imaging, utilising the opportunity afforded by the 
installation of a small animal optical imaging system at the Lionel Opie Pre-Clinical Imaging Facility at UCT.
SASCAR looks forward to an equally exciting 2020, and I would like to extend sincere appreciation to all members of the 
Executive Committee for their efforts over last year, and, in particular, those who directly organised workshops.
neil Davies, President, SASCAr
Delegates in the grounds of StIAS
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tHe SoUtH AFrICAn HeArt ASSoCIAtIon
reSeArCH SCHoLArSHIP
This scholarship is available to full and associate members of the SA Heart® Association living in South Africa. 
It is primarily intended to assist colleagues involved in much-needed research to enhance their research 
programmes.
reqUIreMentS
■	  Applicants need to be fully paid up members/associate members in good standing for at least one year.
■  Applications must include:
	 ■	The applicant’s abbreviated CV
	 ■	A breakdown of the anticipated expenses
	 ■	Ethics approval
	 ■	Full details of the research
	 ■	The completed application form  - please request a fillable MS Word document from erika@saheart.org
	 ■	Contact details of Head of Department or supervisor/mentor
reCoMMenDAtIonS
■   Preference will be given to early and mid-career applicants (<5 years post-qualification as specialist and/or 
<5 years post-PhD qualification).
ConDItIonS
■   Applicants may only submit 1 application every second year. Preference is given to those who have not had 
previous scholarships awarded.
■   Awards are granted for one specific research project. Should that specific project be cancelled or the full 
amount allocated not be utilised for any reason, then the funds must revert to SA Heart®.
APPLICAtIonS MUSt Be eMAILeD to:
erika@saheart.org
tHe SeLeCtIon PAneL WILL reVIeW APPLICAtIonS AnnUALLY AnD tHe CLoSIng 
DAte IS 30 SePteMBer 2020.
One scholarship to a maximum amount of R65 000 will be awarded annually.
SA Heart® commits to inclusive excellence by advancing equity and diversity.
We particularly encourage applications from members of historically under 
represented racial/ethnic groups, women and individuals with disabilities.
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BrAnCH rePortS
JoHAnneSBUrg BrAnCH
the Johannesburg branch committee remains as:
Dr A. Vachiat, Dr M. Lebea, Dr D. Jankelow, Dr R. Leibbrandt, Dr F. Mamdoo, Dr N. Tsabedze, Prof A. Cilliers, Prof P. Manga, 
Dr D. Zachariah, Dr P. Raphulu, Dr S. Hossein and Dr R. Dawood.
The Johannesburg branch of SA Heart welcomed new colleagues into a collective group in April 2019. This is a younger 
committee than previous years. We are fortunate to have some experienced colleagues who have stayed on to guide us, and 
we appreciate their involvement.
Fellows’ presentation
 ■  The Fellows’ presentation took place on 29 June 2019 at the Wanderers. 
 ■  Prof S. Levine, a retired paediatric cardiologist from Johannesburg, was honoured.
 ■  Over 40 delegates attended the meeting and the Fellows’ presentation was well received. 
 ■  Prizes were given to the best presenters:
•  First Prize Dr Nangamso Kukulela 
•  Second Prize Dr Mazwi Nkosi
•  Third Prize Dr Phophi Raphulu
 ■  The branch would like to thank Dr Maimela for organising the event.
SASCI visiting Professor
 ■  Prof Simon Redwood gave a talk on TAVI, which took place on 10 July 2019 at the Wanderers. 
 ■  Over 60 delegates attended. 
 ■  The visiting Professor initiative is to be commended and it is hoped that it will be continued.
Heart Failure CMe
 ■  HeFFSA organised a CME “Challenges in heart failure management” at the Wanderers on 9 September, with good 
attendance. 
Journal club
 ■  Suggestion: To be held on a Saturday morning.
 ■  This meeting to include paediatric and adult cardiologists and both public and private.
We would like to bridge the gap between the younger and the more experienced cardiologists as well as the gap between 
public and private – and look forward to working together.
Thank you to sponsors Pharma Dynamics for the Fellow’s presentation of 29 June 2019.
Ahmed Vachiat, President, Johannesburg Branch
AnnUAL rePortS 2019
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KWAzULU-nAtAL BrAnCH
Committee
Rob Dyer (President) and Jai Patel (Treasurer)
Committee members
Ebrahim Hoosen, Rohan Lutchman, Julian Buckels and Andrew Asherson (Secretary - resigned)
Unfortunately there was no academic activity this year for a number of reasons. The resignation of Andrew Asherson as 
secretary earlier in the year, under pressure of work, impacted on our functioning. Secretarial duties were ultimately taken 
over by Rohan Lutchman, despite his being in the throes of commencing private practice with all the stress and administra- 
tive detail involved in such a move. Our functioning as a group was further hampered by difficulties in getting our account 
“unfrozen” by Standard Bank, and this saga is ongoing and will, no doubt, be dealt with by Dr Jai Patel in his Treasurer’s Report.
All our committee activity has therefore been focused on our role as the Scientific Organising Committee for this year’s 
PASCAR/AfricaPCR/SA Heart® Congress that is being held at Sandton from 31 October - 3 November. All of the above 
committee members and Drs Sajidah Khan, Rob Kleinloog and Haroon Mia have played a part in formulating the programme. 
Particular thanks are due to David Jankelow and to Claire Jettke from Europa for the time they have given us in terms of 
assisting with this daunting task.
The lack of branch activity, while being a matter of regret which certainly needs discussion and improvement, is undoubtedly a 
function of multiple competing demands with which I, personally, have struggled.
rob Dyer, President, Kwazulu-natal Branch
PretorIA BrAnCH
It brings me great pleasure to report back on our SA Heart® Pretoria Branch Activities in 2019. 
Our focus is to serve the educational needs of our branch members (Cardiologists, Fellows, Allieds, EP and Surgeons). Our 
approach is very much to focus on empowering the multi-disciplinary team. 
 ■  Our first meeting took place on 27 February at the Black Bamboo Restaurant, with Dr Donavan Loots as speaker. The 
topic of his talk was “The ethical consideration in the pitfalls of cardiac diagnosis. When is it mandatory to request a post 
mortem.” 23 Delegates attended this meeting, 6 Doctors and 17 Allieds. The feedback we received indicated that the 
delegates found the topic to be very informative.
 ■  For our second meeting we had the privilege of hosting the acclaimed international cardiologist, Prof Simon Redwood, 
from St Guys and Thomas Hospital, London. The topic of his talk was “The Emergence of TAVI as a real option for Patients 
with Aortic Stenosis”, with the aim to interactively share knowledge and experience while focusing on their clinical 
situation, particularities, local experience and constraints – as well as best available evidence. To find consensus with 
South African colleagues on a method of reasoning that may help the group to develop answers to the fundamental 
questions that impact them daily. The 2019 VPP evening lecture series was definitely a huge success according to the 
feedback we received from the 57 delegates who attended the meeting. It was a great presentation, which led to lively 
interactive discussions; 16 Drs and 39 Allied Professionals attended the meeting. This meeting was made possible by 
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longstanding support from Medtronic and Pharma Dynamic that sees a renowned international cardiology Visiting 
Professor travel to South Africa for a 2-month tenure to teach and educate in interventional cardiology (primarily at 
medical schools).
 ■  The third Educational Meeting for 2019 will be held on 11 September, where Dr Jean Vorster will be presenting on Left 
Atrial Plugs for AF-Indications and Contra Indications.
 ■  The fourth Educational Meeting for 2019 is scheduled to take place at the beginning of November, with guest speaker 
Prof Tony Gershlick from the University Hospitals of Leicester, UK. This lecture forms part of the SASCI Vertice Visiting 
Expert Programme that will be focusing on Complex PCI, but specifically Bi-furcations.
We are inviting all our members to attend – including the Allied Professionals. Members must please note that all our meetings 
are CPD-accredited and are offered free of charge. I would like to thank Pharma Dynamics for their continued support and for 
making this multi-evening lecture planning possible.   
Please support the SA Heart® Congress 2019 (Sandton ICC from 31 October - 3 November 2019). The branch will offer 
educational grants (registration) that will be made available to support attendance. You will need to apply to be considered, as 
per the new Medtech and SAMED rules governing HCP sponsorships. 
Please contact Joh-Ann at joh-ann.nice@medsoc.co.za or me (drioebrahim@gmail.com) if you wish to contribute at future 
meetings or wish to suggest appropriate programmes for Pretoria. 
Iftikhar ebrahim, Chairperson, Pretoria Branch
WeStern CAPe BrAnCH
the executive committee members elected for the term 2019/20 are: 
Alfonso Pecararo (President), Jane Moses and Blanche Cupido (Vice-Presidents), Bradley Griffiths (Secretary) and Jens 
Hinzeroth (Treasurer).  Additional members: Hellmuth Weich, Charles Kyriakakis, George Commitis, Andre Brooks and Chevaan 
Hendrikse.
the branch has decided on quarterly meetings.  two meetings have been concluded during 2019:
 ■  The first meeting was held on 04 March 2019. The keynote speaker was Prof D. Blom on the topic of “Statin intoler- 
ance” – followed by case presentations from the different academic units.
 ■  The second meeting was held on 10 June 2019. The keynote speaker was Dr Jane Moses on the topic of “Pacemaker 
implantation and optimisation” – followed by case presentations from the different academic units.
 ■  Two further meetings are planned for 16 September and 11 October 2019 respectively. The keynote speakers invited 
are Dr Mark Abelson (Topic: LAA closure: current indications) and Prof Simon Redwood (Current status of TAVI). At 
both these meetings there will be an opportunity for researchers to present their research, and free registration for 
the annual SA Heart® Congress will be offered to the best presentation during these meetings.
The Western Cape branch is very proud of the excellent attendance of members at these meetings and would like to thank 
our members and sponsors for their contribution to the success of the meetings.
Thank you to sponsors Pfizer, Biotronik and AMGEN for the individual Branch meetings sponsored in 2019.
Alfonso Pecoraro, President: Western Cape Branch of SA Heart®  
AnnUAL rePortS 2019 continued
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All members are invited to the 
SA Heart® AgM 
starting at 17h30  
on Friday 1 november 2019  
in Ballroom 1, Sandton Convention  
Centre, Johannesburg.
All members are urged to attend.
Important information and exciting changes will be 
presented for consideration and voting.




accepted by the relevant congress organising committee, 
the applicant will forfeit his or her sponsorship towards 
the congress. (Application can however be made well in 
advance of the relevant congress but will only be awarded 
on acceptance of the abstract.) A written report on the 
relevant congress attended will need to be submitted by 
the successful applicant within 6 weeks of attending the 
congress. The congress report will be published in the 
South African Heart Association Newsletter.
Applications should be sent to Dr Alfonso Pecoraro, 
President of the Western Cape branch of the South 
African Heart Association, Division of Cardiology, Tyger-
berg Hospital, Francie van Zijl Drive, Tygerberg 7505; or 
alternatively email: pecoraro@sun.ac.za.
Previous recipients of this prestigious award include 
Sandrine Lecour, Roisin Kelle, Liesl Zühlke and Prof Hans 
Strijdom.  
Applications close on 31 January 2020.
LoUIS VogeLPoeL trAVeLLIng SCHoLArSHIP
A gifted and 
enthusiastic 
teacher, he was 
instrumental in  
the training of 
generations of 
undergraduates.
Applications are invited for the annual Louis Vogelpoel Travelling Scholarship for 2020. An amount of up to R20 000 towards the 
travel and accommodation costs of a local or interna- 
tional congress will be offered annually by the Western 
Cape branch of the South African Heart Association in 
memory of one of South Africa’s outstanding cardiologists, 
Dr Louis Vogelpoel. 
Louis Vogelpoel was a pioneer of cardiology in South 
Africa who died in April 2005. He was one of the 
founding members of the Cardiac Clinic at Groote Schuur 
Hospital and the University of Cape Town. He had an 
exceptional career of more than 5 decades as a dis-
tinguished general physician, cardiologist and horticultural 
scientist. Dr Vogelpoel’s commitment to patient-care, 
teaching and personal education is remembered by his 
many students, colleagues and patients. Medical students, 
house officers, registrars and consultants benefited from 
exposure to his unique blend of clinical expertise, extensive 
knowledge, enthusiasm and gracious style. 
A gifted and enthusiastic teacher, he was instrumental in 
the training of generations of undergraduates by regular 
bedside tutorials. He served as an outstanding role model 
for postgraduates and many who have achieved pro-
minence nationally and internationally acknowledged his 
contribution to the development of their careers. 
All applications for the scholarship will be reviewed by the 
executive committee of the Western Cape branch of the 
South African Heart Association. Preference will be given 
to practitioners or researchers in the field of cardiovascular 
medicine who are members of the South African Heart 
Association and are resident in the Western Cape.
Applications should include: (1) A brief synopsis of the 
work the applicant wishes to present at the congress; and 
(2) A brief letter of what the applicant hopes to gain by 
attending the relevant congress. The applicant should sub-
mit an abstract for presentation at the relevant national or 
international meeting. Should such an abstract not be 
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SoUtH AFrICAn HeArt ASSoCIAtIon
Applications for the SA Heart® Travel Scholarship for the fourth term in 2019 are invited to reach the SA Heart® 
Office by 31 December 2019.
The scholarship is for the value of up to R25 000.00 for international meetings and R10 000.00 for local meetings.
This scholarship is available to all members residing in South Africa. It is primarily intended to assist junior 
colleagues to ensure continued participation in local or international scientific meetings or workshops.
reqUIreMentS
■ Applicants must be fully paid-up members for at least 1 year.
reCoMMenDAtIonS
■  Early and mid-career applicants (<5 years post-qualification as specialist and/or <5 years post-PhD qualification).
■  Acceptance of an abstract/poster presentation at the scientific meeting to be attended.
ConDItIonS
■  Awards will not be made for conferences or workshops retrospective to the application submission deadline. 
If the conference is taking place within six (6) weeks following the submission deadline, please indicate this in 
the appropriate place on the application form.
■  It is not a requirement for the abstract to be accepted by the conference travel application closing date. 
Should the acceptance of the paper, including proof of registration not be available at the time of submission 
of the application, then a provisional award may be made pending receipt of the acceptance of the paper.
■  Please ensure that applications are made as well in advance as possible (preferably at least 6 months prior 
to the conference date).
■  Applicants may only submit 1 application every second year. The scholarship is for the value of up to 
R25 000.00 for international meetings and R10 000.00 for local meetings.
■  Awards are only made in the event that a paper or a poster is being presented or in the event of a workshop 
attendance, if the reviewers deem the workshop attendance to be of high impact and consequently of benefit 
to the SA Heart® community.
■  The applicant must ensure that the application is fully completed including the requirements as detailed in the 
checklist section. Applicants are asked to be concise and to only include applicable and relevant information.
■  Awards are granted for 1 specific conference. Should that specific conference be cancelled or the full amount 
allocated not utilised for any reason, then the funds must revert to SA Heart®; and
■  A written report on the relevant congress attended will need to be submitted by the successful applicant 
within 6 weeks of attending the congress. The congress report will be published in the South African Heart 
Association Newsletter.
SUBMISSIon reqUIreMentS
■   For more information and application forms, please visit https://www.saheart.org/cms-home/category/39.
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HeFSSA trAVeL SCHoLArSHIP 
Introduction
The Executive Committee of the Heart Failure Society of South Africa (HeFSSA) has established 
the HeFSSA Travel Scholarship. As part of its contribution towards optimising patient care and 
to enhance and promote local heart failure expertise, HeFSSA supports such an award in South 
Africa. We hope that the information gained during this event and the possibility of sharing your 
experience and opening a dialogue with other specialists, will broaden your knowledge 
regarding new products and therapies in your field of expertise. We also hope that this 
experience will help you to develop educational programmes at your medical institution and to 
share the acquired knowledge with your colleagues actively.
Value
Two travel grants are available annually. Each grant is valued at a maximum of R35 000 which 
may be used towards economy airfare, registration and accommodation. 
eligibility
Candidates may be a medical practitioner in the public or private sector (i.e. a cardiologist, 
physician, internal medicine practitioner, Cardiology Fellow or similar) or researcher (basic 
scientist in heart failure). Applicants must be paid-up members of the SA Heart® Association 
and HeFSSA. The programme/course/conference needs to be internationally or locally 
accredited and focussed on promoting your knowledge of heart failure.
Application
Applications can be submitted to HeFSSA at info@hefssa.org. Please include your contact 
details and hospital affiliation, qualification, private and or public practice, and if you are an RSA 
citizen (or permanent resident). Provide a motivation as to why the specific programme or 
course has been selected and include the programme of the conference (or URL). The HeFSSA 
office will confirm receipt by return email. Application for this award does not guarantee that 
the applicant will receive the award. No correspondence will be entertained after a decision is 
made. The applicant will be notified of the outcome of the applications within 4 weeks of 
receipt.
ProCeSS AnD terms
The grant recipient needs to book, pay and then claim back (with proof documentation) from 
HeFSSA. Refund will be actioned within 24 hours. Twenty percent of the grant amount will be 
retained by HeFSSA (R7 000) and will be paid to the recipient as soon as CPD certificate and 
a meeting report is received.
Within one month of returning from the conference, the recipient must submit a substantial 
evaluation/review of the course content. This should reflect on key lectures and late-breaking 
trials as well as other sessions attended, which will impact on the practice going forward. 
Include some photographs. The purpose of this report is to share knowledge gained that could 
impact on colleagues’ practices. The report should be included in the SA Heart® newsletter 
and/or the HeFSSA newsletter. 
HefSSA strongly recommends that the recipient create the opportunity to give feedback 
through a lecture delivered at appropriate educational forums (please confirm with HefSSA 
when these take place).
Should the recipient not attend the conference, HefSSA reserves the right to request 
repay-ment of any monies paid.
“enHAnCIng HeArt FAILUre MAnAgeMent In SoUtH AFrICA”
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